BioLineRx is a biopharmaceutical company focused on oncology. It in-licenses compounds, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for clinical development and/or commercialization. The company provides therapeutic candidates for stem cell mobilization, pancreatic cancer, AML (acute myeloid leukemia), gastric cancer, and solid tumors.